Targeting Cellular Senescence to Enhance Human Endometrial Stromal Cell Decidualization and Inhibit Their Migration
Biomolecules · 2025
DOI: 10.3390/biom15060873 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biomolecules, 2025. Verfasst von Julia Delenko und 12 weiteren Autor:innen. Beteiligte Einrichtung: Northwell, 2000 Marcus Ave, Suite 300, New Hyde Park, NY 11042, USA. Hauptthemen laut MEDLINE: Cellular Senescence, Stromal Cells, Cell Movement, Endometrium. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 75 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Engineering and Physical Sciences Research Council, Feinstein Institutes, Northwell Health Innovations Award, as well as Advancing Women in Science and Medicine (AWSM) and the Katz Institute for Women's Health (…, Feinstein Institutes.
Abstract (Originalsprache)
Cellular senescence leads to stable cell cycle arrest and an inflammatory senescence-associated secretory phenotype that varies with stressor and cell type. To mitigate these effects and improve health, senotherapeutics (e.g., senolytics and senomorphics) have been developed. Senescent-like endometrial stromal cells (eSCs) lining the uterus of patients with endometriosis and infertility are proposed to impair decidualization, a differentiation process required for uterine receptivity in humans. Quercetin, a natural flavonoid senolytic, dramatically improves decidualization and reduces endometriosis in rodent models. However, little is known about the comparative effects of various senotherapeutics on eSCs. Using menstrual effluent-derived eSCs, we evaluated the effects of flavonoid and non-flavonoid compounds on eSC functions associated with endometriosis, aiming to identify optimal senotherapeutics for future clinical trials. Among flavonoids tested, all senolytics (quercetin, fisetin, and luteolin) and kaempferol, a senomorphic, significantly improved decidualization without cytotoxicity. Although non-flavonoids exhibited notable cytotoxicity, dasatinib, but neither ABT-737 nor navitoclax, enhanced decidualization. Flavonoid senotherapeutics and dasatinib significantly inhibited eSC migration. Mechanistic studies revealed that all flavonoids and dasatinib suppressed AKT phosphorylation and upregulated p53 expression. Notably, only quercetin and fisetin reduced ERK1/2 phosphorylation. Furthermore, flavonoid-senolytics and dasatinib consistently eliminated senescent eSCs. These findings support future studies to assess the therapeutic potential of in vivo supplementation with flavonoid senolytics on eSC function using menstrual effluent.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Northwell, 2000 Marcus Ave, Suite 300, New Hyde Park, NY 11042, USA.
- The Feinstein Institutes for Medical Research/Northwell, 350 Community Drive, Manhasset, NY 11030, USA.
- The Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, 500 Hofstra Blvd, Hempstead, NY 11549, USA.
- Early Cancer Institute, Department of Oncology, University of Cambridge, Hills Road, Cambridge CB2 0XZ, UK.
- Department of Chemical Engineering and Biotechnology, University of Cambridge, Philippa Fawcett Drive, Cambridge CB3 0AS, UK.
ORCID-Profile: Julia Delenko, Nathaniel Hyman, Polona Safaric Tepes, Andrew J Shih, Andrew G Baker, Ljiljana Fruk, Peter K Gregersen, Christine N Metz
Förderung
- Engineering and Physical Sciences Research Council
- Feinstein Institutes, Northwell Health Innovations Award, as well as Advancing Women in Science and Medicine (AWSM) and the Katz Institute for Women's Health (…
- Feinstein Institutes
- Northwell Health Innovations Award
- Advancing Women in Science and Medicine (AWSM)
- Katz Institute for Women’s Health (KIWH) at Northwell
- EPSRC Impact Accelerator Award
- CRUK Cambridge Centre Early Detection Program
Zitieren
APA
Delenko, J., Hyman, N., Chatterjee, P. K., Safaric Tepes, P., Shih, A. J., Xue, X., Gurney, J., Baker, A. G., Wei, C., Munoz Espin, D., Fruk, L., Gregersen, P. K., & Metz, C. N. (2025). Targeting Cellular Senescence to Enhance Human Endometrial Stromal Cell Decidualization and Inhibit Their Migration. Biomolecules. https://doi.org/10.3390/biom15060873
Vancouver
Delenko J, Hyman N, Chatterjee PK, Safaric Tepes P, Shih AJ, Xue X, et al. Targeting Cellular Senescence to Enhance Human Endometrial Stromal Cell Decidualization and Inhibit Their Migration. Biomolecules. 2025. doi:10.3390/biom15060873
BibTeX
@article{Delenko2025,
author = {Delenko, Julia and Hyman, Nathaniel and Chatterjee, Prodyot K and Safaric Tepes, Polona and Shih, Andrew J and Xue, Xiangying and Gurney, Jane and Baker, Andrew G and Wei, Cheng and Munoz Espin, Daniel and Fruk, Ljiljana and Gregersen, Peter K and Metz, Christine N},
title = {Targeting Cellular Senescence to Enhance Human Endometrial Stromal Cell Decidualization and Inhibit Their Migration},
journal = {Biomolecules},
year = {2025},
doi = {10.3390/biom15060873}
}
EUVIMED